Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab
A. M. Vignola, J. Bousquet, J. Maspero, H. Fox, S. Hedgecock, M. Blogg (Palermo, Italy; Montpellier, France; Buenos Aires, Argentina; Horsham, United Kingdom)
Source: Annual Congress 2003 - Newer and alternative non-steroidal treatments for asthmatic inflammation
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. M. Vignola, J. Bousquet, J. Maspero, H. Fox, S. Hedgecock, M. Blogg (Palermo, Italy; Montpellier, France; Buenos Aires, Argentina; Horsham, United Kingdom). Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab. Eur Respir J 2003; 22: Suppl. 45, 1388
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Omalizumab in the treatment of perennial allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 37s Year: 2001
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Specific allergen immunotherapy of asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006
Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006
Levocetirizine in the treatment of perennial allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002
Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 121s Year: 2006
Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006
The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: 330 Year: 2004
Impact of allergic rhinitis on asthma Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy Year: 2012
Efficacy of ruzam in the treatment of patients with perennial allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004
Treatment and outcomes in patients with asthma and allergic rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007
Diagnosis and treatment of allergic rhinitis in asthmatic children Source: Annual Congress 2009 - Allergic rhinitis and its impact on asthma in children Year: 2009
Asthma among allergic rhinitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 108s Year: 2003
The effect of cockroach-sensitivity on allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 436s Year: 2001
Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma Source: Eur Respir J 2002; 20: 73-78 Year: 2002
Is montelukast effective in allergic rhinitis in children? Source: Eur Respir J 2006; 28: Suppl. 50, 263s Year: 2006